loadpatents
name:-0.016244888305664
name:-0.013463020324707
name:-0.0046279430389404
Limmert; Michael Patent Filings

Limmert; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Limmert; Michael.The latest application filed is for "bendamustine derivatives and related compounds, and medical use thereof in cancer therapy".

Company Profile
5.17.15
  • Limmert; Michael - Dresden DE
  • - Dresden DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,526,290 - Schickaneder , et al. J
2020-01-07
Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
Grant 10,442,773 - Schwab , et al. Oc
2019-10-15
Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy
Grant 10,294,208 - Schickaneder , et al.
2019-05-21
Bendamustine Derivatives and Related Compounds, and Medical Use Thereof in Cancer Therapy
App 20170313663 - SCHICKANEDER; Helmut ;   et al.
2017-11-02
Method For The Purification Of Epothilones Via Crystallization
App 20160185793 - LUBBE; Mathias ;   et al.
2016-06-30
Amorphous Letermovir And Solid Pharmaceutical Formulations Thereof For Oral Administration
App 20160145216 - SCHWAB; Wilfried ;   et al.
2016-05-26
Aryl-substituted and/or heteroaryl-substituted main group element halides and/or pseudohalides, use of main group element halides and/or pseudohalides, organic semiconducting matrix material, electronic and optoelectronic components
Grant 9,156,868 - Zeika , et al. October 13, 2
2015-10-13
Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic component
Grant 9,118,019 - Limmert , et al. August 25, 2
2015-08-25
Method for preparing doped organic semiconductor materials and formulation utilized therein
Grant 9,065,055 - Zeika , et al. June 23, 2
2015-06-23
Bendamustine Derivatives And Related Compounds, And Medical Use Thereof In Cancer Therapy
App 20150152066 - Schickaneder; Helmut ;   et al.
2015-06-04
Process for the production of moxonidine
Grant 9,040,697 - Hofmeier , et al. May 26, 2
2015-05-26
Use of a precursor of an N-dopant for doping an organic semiconductive material, precursor and electronic or optoelectronic component
Grant 08920944 -
2014-12-30
Use of a precursor of an N-dopant for doping an organic semiconductive material, precursor and electronic or optoelectronic component
Grant 8,920,944 - Limmert , et al. December 30, 2
2014-12-30
3-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol Resin Complex
App 20140356314 - HARTENHAUER; Helge ;   et al.
2014-12-04
Esters of bendamustine and related compounds, and medical use thereof
Grant 8,809,549 - Schickaneder , et al. August 19, 2
2014-08-19
Process For The Production Of Moxonidine
App 20140228383 - HOFMEIER; Harald ;   et al.
2014-08-14
Esters Of Bendamustine And Related Compounds, And Medical Use Thereof
App 20130289032 - SCHICKANEDER; Helmut ;   et al.
2013-10-31
Process for the preparation of bendamustine hydrochloride and related compounds
App 20130184471 - Schickaneder; Helmut ;   et al.
2013-07-18
Use of heterocyclic radicals for doping organic semiconductors
Grant 8,431,046 - Zeika , et al. April 30, 2
2013-04-30
Use of a metal complex as an n-Dopant for an organic semiconducting matrix material, organic of semiconducting material and electronic component, and also a dopant and ligand and process for producing same
Grant 8,258,501 - Werner , et al. September 4, 2
2012-09-04
Heterocyclic Radical or Diradical, The Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
App 20120146012 - Limmert; Michael ;   et al.
2012-06-14
Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic component
Grant 8,134,146 - Limmert , et al. March 13, 2
2012-03-13
Use of Heterocyclic Radicals for Doping Organic Semiconductors
App 20110108772 - Zeika; Olaf ;   et al.
2011-05-12
Method for Preparing Doped Organic Semiconductor Materials and Formulation Utilized Therein
App 20100233844 - Zeika; Olaf ;   et al.
2010-09-16
Use of a Precursor of an N-Dopant for Doping an Organic Semiconductive Material, Precursor and Electronic or Optoelectronic Component
App 20100187515 - Limmert; Michael ;   et al.
2010-07-29
Aryl-substituted And/or Heteroaryl-substituted Main Group Element Halides And/or Pseudohalides, Use Of Main Group Element Halides And/or Pseudohalides, Organic Semiconducting Matrix Material, Electronic And Optoelectronic Components
App 20100140566 - Zeika; Olaf ;   et al.
2010-06-10
Use of a Metal Complex as an N-Dopant for an Organic Semiconducting Matrix Material, Organic of Semiconducting Material and Electronic Component, and also a Dopant and Ligand and Process for Producing same
App 20090212280 - Werner; Ansgar ;   et al.
2009-08-27
Heterocyclic Radical or Diradical, the Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
App 20070252140 - Limmert; Michael ;   et al.
2007-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed